Insider · CIK 0001310845

Beardsley Robert A

Reports to the SEC for 3 companies · WARMINSTER, PA

sec.gov

Transactions

Companies

Filings

CIK

0001310845

Forms 4 and 5

Insider transactions

24 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-10-01	ABUSArbutus Biopharma CorpD Disposition to Issuer	Director	DDisposition to Issuer	−17.9K sh	$5.00	−$89.7K	14,328
2026-09-18	ABUSArbutus Biopharma CorpM Exercise/Conversion	Director	MExercise/Conversion	+78.8K sh	$4.24	+$334K	131,333
2026-09-18	ABUSArbutus Biopharma CorpM Exercise/Conversion	Director	MExercise/Conversion	+52.5K sh	$3.20	+$168K	52,533
2026-09-18	ABUSArbutus Biopharma Corp · Stock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−78.8K sh	—	—	0
2026-09-18	ABUSArbutus Biopharma Corp · Stock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−52.5K sh	—	—	105,067
2026-09-18	ABUSArbutus Biopharma CorpF Tax Payment	Director	FTax Payment	−99.1K sh	$5.07	−$502K	32,276
2026-06-08	ABUSArbutus Biopharma Corp · Stock Option (Right to Buy)A Award	Director	AAward	+78.8K sh	—	—	78,800
2025-03-18	ABUSArbutus Biopharma Corp · Stock Option (Right to Buy)A Award	Director	AAward	+158K sh	—	—	157,600
2023-02-25	GRTXGalera Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Chief Operating Officer	AAward	+135K sh	—	—	135,000
2022-11-21	GRTXGalera Therapeutics, Inc.M Exercise/Conversion	Chief Operating Officer	MExercise/Conversion	+10K sh	$1.07	+$10.7K	108,191
2022-11-21	GRTXGalera Therapeutics, Inc. · Stock OptionM Exercise/Conversion	Chief Operating Officer	MExercise/Conversion	−10K sh	—	—	75,651
2022-09-12	GRTXGalera Therapeutics, Inc.M Exercise/Conversion	Chief Operating Officer	MExercise/Conversion	+10K sh	$1.07	+$10.7K	98,191
2022-09-12	GRTXGalera Therapeutics, Inc. · Stock OptionM Exercise/Conversion	Chief Operating Officer	MExercise/Conversion	−10K sh	—	—	85,651
2022-02-28	GRTXGalera Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Chief Operating Officer	AAward	+75K sh	—	—	75,000
2021-12-17	GRTXGalera Therapeutics, Inc. · Stock OptionM Exercise/Conversion	Chief Operating Officer	MExercise/Conversion	−20K sh	—	—	95,651
2021-12-17	GRTXGalera Therapeutics, Inc.M Exercise/Conversion	Chief Operating Officer	MExercise/Conversion	+20K sh	$1.07	+$21.4K	88,191
2021-01-26	GRTXGalera Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Chief Operating Officer	AAward	+75K sh	—	—	75,000
2020-01-31	GRTXGalera Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Chief Operating Officer	AAward	+74.4K sh	—	—	74,435
2019-11-12	GRTXGalera Therapeutics, Inc. · Series C Preferred StockC Conversion	Chief Operating Officer	CConversion	−6,774 sh	—	—	0
2019-11-12	GRTXGalera Therapeutics, Inc. · Series A Preferred StockC Conversion	Chief Operating Officer	CConversion	−68.9K sh	—	—	0
2019-11-12	GRTXGalera Therapeutics, Inc. · Series B Preferred StockC Conversion	Chief Operating Officer	CConversion	−2,000 sh	—	—	0
2019-11-12	GRTXGalera Therapeutics, Inc.C Conversion	Chief Operating Officer	CConversion	+15.4K sh	—	—	68,191
2007-05-23	COLLAGENEX PHARMACEUTICALS INCStock Option (Right to Buy)A Award	Director	AAward	+12K sh	—	—	61,000
2005-05-25	COLLAGENEX PHARMACEUTICALS INCCommon StockA Award	Director	AAward	+12K sh	—	—	37,000

Recent filings

Accepted (ET)
Oct 74
Beardsley Robert A0001447028-26-000061
SEC(opens sec.gov)
Sep 234
Beardsley Robert A0001447028-26-000050
SEC(opens sec.gov)
Jun 104
Beardsley Robert A0001447028-26-000039
SEC(opens sec.gov)
Mar 204
Beardsley Robert A0001447028-25-000075
SEC(opens sec.gov)
Feb 284
Beardsley Robert A0000899243-23-006475
SEC(opens sec.gov)
Nov 224
Beardsley Robert A0000899243-22-036697
SEC(opens sec.gov)
Sep 134
Beardsley Robert A0000899243-22-030911
SEC(opens sec.gov)
Mar 24
Beardsley Robert A0000899243-22-008585
SEC(opens sec.gov)
Dec 204
Beardsley Robert A0000899243-21-049011
SEC(opens sec.gov)
Jan 284
Beardsley Robert A0000899243-21-003611
SEC(opens sec.gov)
Feb 44
Beardsley Robert A0000899243-20-002866
SEC(opens sec.gov)
Nov 124
Beardsley Robert A0000899243-19-027114
SEC(opens sec.gov)

Companies

Address

C/O ARBUTUS BIOPHARMA CORPORATION 701 VETERANS CIRCLE

WARMINSTER, PA, 18974